![]() ![]() Conclusions: Severe macular edema did not evolve in the AlzerĪnd Diamel group. ![]() In visual acuity one year after treatment. This decrease in thickness was statistically ![]() In the patients treated with Alzer and Diamel. Was a clinical improvement in the macular thickness upon the conclusion of the study Were given an initial clinical evaluation, blood testing and ophthalmological evaluationĪt the start of treatment and after one year of follow-up. To two groups: one received Alzer plus Diamel (n = 32) and the other group received Alzer placebo + Diamel Of Havana from January 2016 to December 2016. Retinopathy, who attended the ophthalmology service of the Institute of Endocrinology With non-severe diabetic macular edema over the course of non-proliferative diabetic MaterialsĪnd Methods: A phase II double-blind clinical trial was conducted in 64 patients Retina among patients with mild to moderate diabetic macular edema. The effect of Alzer along with Diamel in reduction of the thickness of the macular More advanced clinical presentations that are harder to treat. Reducing the thickness of the macular retina and preventing the progression of other The Diamel nutritional supplement has been shown to be effective on glycemic controlĪnd could represent a treatment alternative for mild to moderate macular edema by Which are two of the mechanisms implicated in the pathogenesis of diabetic macularĮdema), which has been used on other non-diabetic macular conditions, along with The nutritional supplementĪlzer (whose primary active ingredient is Ginkgoīiloba, a powerful antioxidant that acts on vascular factors and oxidative damage, To be the treatment of choice in conjunction with the use of steroids and anti-angiogenics,īut these treatments include possible ocular complications. The main cause of low vision in diabetic patients. ![]()
0 Comments
Leave a Reply. |